Dr Hiediliza Y Tan, MD, | |
907 E Lamar Alexander Pkwy, Maryville, TN 37804-5015 | |
(865) 983-7211 | |
(865) 273-1755 |
Full Name | Dr Hiediliza Y Tan |
---|---|
Gender | Female |
Speciality | Infectious Disease |
Experience | 34 Years |
Location | 907 E Lamar Alexander Pkwy, Maryville, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306810395 | NPI | - | NPPES |
3872046 | Medicaid | TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 36002 (Tennessee) | Secondary |
207RI0200X | Internal Medicine - Infectious Disease | 36002 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Blount Memorial Hospital | Maryville, TN | Hospital |
Mailing Address | Practice Location Address |
---|---|
Dr Hiediliza Y Tan, MD, Po Box 688, Alcoa, TN 37701-0688 Ph: (865) 273-1752 | Dr Hiediliza Y Tan, MD, 907 E Lamar Alexander Pkwy, Maryville, TN 37804-5015 Ph: (865) 983-7211 |
News Archive
Lung cancers account for approximately 25 percent of all cancer deaths. Even among those who do not smoke, 1 in 15 men and 1 in 17 women are expected to develop lung cancer in their lifetime, according to the American Cancer Society.
Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45 percent, from 1.6 million in 2010 to 2.3 million in 2030, with a dramatic spike in incidence predicted in the elderly and minority populations, according to research from The University of Texas M. D. Anderson Cancer Center.
A recent tour-de-force study by the US researchers describes a comprehensive approach to completely map mutations to the SARS-CoV-2 receptor-binding domain (RBD) that escape antibody binding – enabling, in turn, rational design of antibody therapeutics and appraisal of the antigenic consequences of viral evolution. The results are currently available in a bioRxiv preprint paper.
CytomX Therapeutics, a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today entered into a collaboration with The University of Texas MD Anderson Cancer Center to research Probody-enabled chimeric antigen receptor natural killer (CAR-NK) cell therapies, to be known as ProCAR-NK cell therapies.
Stiffer breast tissue creates an environment more prone to cancer by enabling the disease to interfere with the surrounding healthy cells, according to a recent study published in Biomaterials.
› Verified 7 days ago
Kevin Mccoy James, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 252 Cherokee Professional Park, Maryville, TN 37804 Phone: 865-980-5200 Fax: 865-980-5201 | |
Jack T Roberts Jr., MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-980-4897 Fax: 865-977-4793 | |
Bhavin Patel, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 162 Bmh Physicians Office Bldg, Maryville, TN 37804 Phone: 865-238-6161 Fax: 862-238-6170 | |
Kevin Michael Donovan, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-980-4897 Fax: 865-977-4722 | |
Dr. Matthew J Mccarty, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 220 Bmh Cancer Center, Maryville, TN 37804 Phone: 865-977-1065 Fax: 865-982-8538 | |
Dr. Joseph Duane Payne, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1103 E. Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-977-1818 Fax: 865-977-1801 | |
Dr. Michael John Coffey, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1706 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-983-0073 Fax: 865-984-1731 |